K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

By S. Massry, J. Coburn, Glenn M. Chertow, K. Hruska, C. Langman, H. Malluche, K. Martin, L. Mccann, J. McCarthy, S. Moe and 71 more. American Journal of Kidney Diseases, 2003

2,608 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/8a4f84e73eef2c7568ca12905281fe8364e1d5c7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. M. Molitch
2. A. Levin
3. L. Williams
4. G. Bakris
5. J. Tian
6. M. Smulders
7. V. Basevi

Citations in the corpus

• Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. (2007, result): “This finding may have therapeutic ramifications as recent Kidney Disease Outcomes Quality Initiative guidelines currently suggest the use of ergocalciferol (vitamin D2) as the initial treatment for HPTH in CKD stage 3 and 4.(16) However, the findings herein of an early low levels of 1,25 OH2 D3 and ”